Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
SOPHiA GENETICS
SOPH
$216M
| $51K | ﹤0.01% |
19,900
-1,700
| -8% | -$4.36K |
|
3402
Surf Air Mobility
SRFM
$177M
| $51K | ﹤0.01% |
+4,457
| New | +$51K |
|
3403
WidePoint Corp
WYY
$55.3M
| $51K | ﹤0.01% |
29,900
+4,000
| +15% | +$6.82K |
|
3404
Ekso Bionics
EKSO
$10.2M
| $50K | ﹤0.01% |
4,581
+741
| +19% | +$8.09K |
|
|
FURY
3405
Fury Gold Mines
FURY
$113M
| $50K | ﹤0.01% |
145,102
+2,114
| +1% | +$728 |
|
|
GP
3406
GreenPower Motor Co
GP
$11.1M
| $49K | ﹤0.01% |
15,600
-12,400
| -44% | -$38.9K |
|
3407
Vista Gold
VGZ
$199M
| $49K | ﹤0.01% |
112,863
-320,737
| -74% | -$139K |
|
|
LVOX
3408
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $49K | ﹤0.01% |
14,700
-700
| -5% | -$2.33K |
|
|
BEDU
3409
Bright Scholar Education Holdings
BEDU
$48.5M
| $48K | ﹤0.01% |
42,025
-2,300
| -5% | -$2.63K |
|
3410
FibroGen
FGEN
$50.3M
| $48K | ﹤0.01% |
+2,240
| New | +$48K |
|
|
MOGU
3411
MOGU Inc
MOGU
$37.7M
| $48K | ﹤0.01% |
22,757
-4,300
| -16% | -$9.07K |
|
|
BMTX
3412
DELISTED
BM Technologies, Inc.
BMTX
| $48K | ﹤0.01% |
24,200
+5,700
| +31% | +$11.3K |
|
3413
Inuvo
INUV
$52.3M
| $47K | ﹤0.01% |
21,940
-2,870
| -12% | -$6.15K |
|
3414
CASI Pharmaceuticals
CASI
$36.1M
| $46K | ﹤0.01% |
17,800
+2,700
| +18% | +$6.98K |
|
3415
Flora Growth
FLGC
$13.8M
| $46K | ﹤0.01% |
1,023
+433
| +73% | +$19.5K |
|
3416
Lipocine
LPCN
$15.9M
| $46K | ﹤0.01% |
15,597
+5,200
| +50% | +$15.3K |
|
|
KA
3417
DELISTED
Kineta, Inc. Common Stock
KA
| $46K | ﹤0.01% |
13,544
-13,372
| -50% | -$45.4K |
|
|
SCPX
3418
DELISTED
Scorpius Holdings, Inc.
SCPX
| $46K | ﹤0.01% |
22
+4
| +22% | +$8.36K |
|
3419
Context Therapeutics
CNTX
$75M
| $45K | ﹤0.01% |
30,100
+1,800
| +6% | +$2.69K |
|
3420
Sky Harbour Group
SKYH
$344M
| $45K | ﹤0.01% |
+10,000
| New | +$45K |
|
3421
TScan Therapeutics
TCRX
$105M
| $45K | ﹤0.01% |
17,700
-129,762
| -88% | -$330K |
|
|
BEST
3422
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $45K | ﹤0.01% |
20,400
+500
| +3% | +$1.1K |
|
|
ENG
3423
DELISTED
ENGlobal Corp
ENG
| $45K | ﹤0.01% |
16,485
-14,528
| -47% | -$39.7K |
|
|
DHC
3424
Diversified Healthcare Trust
DHC
$1.09B
| $44K | ﹤0.01% |
+22,900
| New | +$44K |
|
3425
Xilio Therapeutics
XLO
$37.8M
| $44K | ﹤0.01% |
20,700
+400
| +2% | +$850 |
|